Theravance Biopharma Inc
(NAS:TBPH)
$
8.09
0.08 (1%)
Market Cap: 395.78 Mil
Enterprise Value: 346.36 Mil
PE Ratio: 0
PB Ratio: 2.04
GF Score: 66/100 Theravance Biopharma Inc (TBPH) Transcripts
- Q2 2024 Theravance Biopharma Inc Earnings Call TranscriptAug 05, 2024$9.59 (-0.52%)Earnings
- Q1 2024 Theravance Biopharma Inc Earnings Call TranscriptMay 13, 2024$9.58 (+2.13%)Earnings
- Q4 2023 Theravance Biopharma Inc Earnings Call TranscriptFeb 26, 2024$9.23 (+2.78%)Earnings
- Q3 2023 Theravance Biopharma Inc Earnings Call TranscriptNov 07, 2023$9.73 (-2.41%)Earnings
- Q2 2023 Theravance Biopharma Inc Earnings Call TranscriptAug 07, 2023$9.83 (-1.21%)Earnings
- Q1 2023 Theravance Biopharma Inc Earnings Call TranscriptMay 08, 2023$11.33Earnings
- Theravance Biopharma Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Q4 2022 Theravance Biopharma Inc Earnings Call TranscriptFeb 27, 2023$10.56 (+6.99%)Earnings
- Q3 2022 Theravance Biopharma Inc Earnings Call TranscriptNov 07, 2022$10.05 (+0.90%)Earnings
- Theravance Biopharma Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 Theravance Biopharma Inc Earnings Call TranscriptAug 04, 2022$9.48 (+2.60%)Earnings
- Theravance Biopharma Inc to Sell Trelegy Ellipta Royalty Interests to Royalty Pharma - Conference Call TranscriptJul 13, 2022
- Q1 2022 Theravance Biopharma Inc Earnings Call TranscriptMay 05, 2022$9.73 (-5.53%)Earnings
- Q4 2021 Theravance Biopharma Inc Earnings Call TranscriptFeb 23, 2022$9.11 (-2.46%)Earnings
- Theravance Biopharma Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Q3 2021 Theravance Biopharma Inc Earnings Call TranscriptNov 03, 2021$8.08 (+1.76%)Earnings
- Theravance Biopharma Inc Strategic Actions To Focus On Respiratory Disease Portfolio Corporate Call TranscriptSep 15, 2021
- Theravance Biopharma Inc Announces Results from Phase 2B Study of Izencitinib - Conference Call TranscriptAug 23, 2021
- Q2 2021 Theravance Biopharma Inc Earnings Call TranscriptAug 03, 2021$13.63 (-1.37%)Earnings
- Theravance Biopharma Inc TD-0903 Clinical Data Update Call TranscriptJun 21, 2021
- Theravance Biopharma Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Theravance Biopharma Inc Earnings Call TranscriptMay 04, 2021$19.88 (+0.10%)Earnings
- Theravance Biopharma Inc Annual Shareholders Meeting TranscriptApr 27, 2021
- Q4 2020 Theravance Biopharma Inc Earnings Call TranscriptFeb 23, 2021$17.65 (-2.38%)Earnings
- Theravance Biopharma Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Theravance Biopharma Inc Earnings Call TranscriptNov 05, 2020$19.48 (+0.52%)Earnings
- Theravance Biopharma Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Theravance Biopharma Inc Earnings Call TranscriptAug 06, 2020$20.84 (+2.26%)Earnings
- Q1 2020 Theravance Biopharma Inc Earnings Call TranscriptMay 06, 2020$28.13 (+1.52%)Earnings
- Theravance Biopharma, Inc. - Special Call TranscriptApr 09, 2020
- Q4 2019 Theravance Biopharma Inc Earnings Call TranscriptFeb 24, 2020$23.51 (-8.77%)Earnings
- Theravance Biopharma Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Theravance Biopharma Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Theravance Biopharma Inc Earnings Call TranscriptNov 05, 2019$17.12 (+0.53%)Earnings
- Theravance Biopharma Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Theravance Biopharma Inc Earnings Call TranscriptJul 31, 2019$20.85 (+4.83%)Earnings
- Q1 2019 Theravance Biopharma Inc Earnings Call TranscriptMay 07, 2019$24.45 (-2.55%)Earnings
- Q4 2018 Theravance Biopharma Inc Earnings Call TranscriptFeb 26, 2019$24.79 (+0.98%)Earnings
- 1